Ledertrexate (Methotrexate Disodium)

Methotrexate Disodium, the active ingredient in Ledertrexate, is an antimetabolite (folate antagonist) presented as an oral dosage form for systemic use. It is employed to treat autoimmune disorders such as rheumatoid arthritis and psoriasis, as well as specific cancers including acute lymphoblastic leukemia and non‑Hodgkin lymphoma in adult patients.

GNH USA supplies Ledertrexate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for importers and timely delivery.

Methotrexate Disodium is used in several immune‑mediated and oncologic conditions, targeting abnormal cell proliferation.

- Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Psoriasis: decreases skin plaque formation and severity. - Acute lymphoblastic leukemia: induces remission by inhibiting malignant lymphoblast proliferation. - Non‑Hodgkin lymphoma: contributes to tumor control through cytotoxic effects. - Ectopic pregnancy: terminates trophoblastic tissue when surgical management is not chosen.

Methotrexate Disodium may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea and vomiting. - Fatigue and malaise. - Oral mucosal ulceration. - Elevated liver enzymes. - Mild leukopenia or thrombocytopenia.

Serious or Rare Side Effects: - Severe hepatotoxicity or fibrosis. - Pulmonary fibrosis or interstitial pneumonitis. - Life‑threatening bone marrow suppression. - Acute renal failure. - Severe infection due to immunosuppression.

When prescribing Methotrexate Disodium, clinicians should observe several safety measures to minimize risk.

- Pregnancy contraindication: avoid use in pregnant women (Category X). - Liver function monitoring: perform baseline and periodic LFTs. - Hematologic monitoring: check complete blood count regularly. - Live vaccine avoidance: do not administer live attenuated vaccines during therapy. - Renal impairment dose adjustment: reduce dose or increase monitoring. - Store below 25°C: keep in the original pack, protect from moisture and light.

Methotrexate Disodium interacts with several medicines, requiring careful management.

Major Interactions (Avoid): - NSAIDs: increase methotrexate toxicity. - Other folate antagonists: additive bone marrow suppression. - Trimethoprim‑sulfamethoxazole: heightened risk of myelosuppression. - Live vaccines: risk of severe infection. - Alcohol: potentiates hepatotoxicity.

Moderate Interactions (Monitor Closely): - Proton pump inhibitors: may affect absorption. - Diuretics: can raise serum methotrexate levels. - ACE inhibitors: possible renal function impact. - Oral contraceptives: may reduce efficacy of methotrexate. - Allopurinol: may increase methotrexate plasma concentration.